Anti-Gli1 antibody [EPR4523]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
3
(2 Reviews)
|
(43 Publications)
Rabbit Recombinant Monoclonal GLI1 antibody. Suitable for WB and reacts with Human samples. Cited in 43 publications.
View Alternative Names
GLI, GLI1, Zinc finger protein GLI1, Glioma-associated oncogene, Oncogene GLI
- WB
Lab
Western blot - Anti-Gli1 antibody [EPR4523] (AB134906)
Western blot : Rabbit Monoclonal [EPR4523] to Gli1 ab134906 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta.
A band was observed at 145 kDa in Wild-type A549 cell lysates with no signal observed at this size in GLI1 knockout A549 cell line.
To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.
Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-Gli1 antibody [EPR4523] (ab134906) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 40 µg
Lane 2:
Human GLI1 knockout A549 cell line at 20 µg
Lane 2:
Western blot - Human GLI1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-gli1-knockout-a549-cell-line-ab277815'>ab277815</a>) at 20 µg
Lane 3:
SH-SY5Y cell lysate at 40 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 118 kDa
Observed band size: 145 kDa
false
- WB
Supplier Data
Western blot - Anti-Gli1 antibody [EPR4523] (AB134906)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
The expression level of Gli1 in HepG2 and RD are consistent with describes in PMID : 19189974 and PMID : 32493277.
Negative control : HepG2 and RD (PMID : 19189974 and PMID : 32493277).
All lanes:
Western blot - Anti-Gli1 antibody [EPR4523] (ab134906) at 1/1000 dilution
Lane 1:
A673 (human muscle Ewing's Sarcoma) whole cell lysate at 20 µg
Lane 2:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
RD (Human muscle rhabdomyosarcoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 118 kDa
Observed band size: 160 kDa
true
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Gli1 antibody [EPR4523] (AB134906)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Western blot - Anti-Gli1 antibody [EPR4523] (ab134906) at 1/1000 dilution
Lane 1:
RMS 13 (human rhabdomyosarcoma fibroblast) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
RMS 13 (human rhabdomyosarcoma fibroblast) transfected with siRNA specifically targeting Gli1 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 118 kDa
Observed band size: 150 kDa
true
Exposure time: 180s
Reactivity data
Product details
This antibody was developed as part of a collaboration with the lab of Martin Fernandez-Zapico at the Mayo Clinic.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Gli1 functions to regulate cellular proliferation differentiation and survival. As part of the Gli protein family Gli1 operates in concert with other members such as Gli2 and Gli3 though it lacks significant repressor activity unlike some of its counterparts. It acts prominently in developmental processes controlling the expression of genes critical for embryogenesis. Gli1 also maintains stem cell populations and sustains tissue homeostasis in adults particularly in contexts where rapid cell division is necessary like wound healing.
Pathways
Gli1 plays a substantial role in the Hedgehog signaling pathway and interacts dynamically with this system. It receives upstream activation from the Smoothened protein which conveys signals in response to Hedgehog ligand availability. Additionally the Gli1 pathway overlaps with WNT signaling during various developmental stages. Through these interactions Gli1 coordinates tightly with other proteins to effect changes in target gene transcription that influence cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (43)
Recent publications for all applications. Explore the full list and refine your search
The Journal of reproduction and development 71:161-167 PubMed40301068
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Kaohsiung journal of medical sciences 41:e12930 PubMed39789998
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:111255 PubMed39620128
2024
Applications
Unspecified application
Species
Unspecified reactive species
European journal of histochemistry : EJH 68: PubMed39526436
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular histology 55:1259-1270 PubMed39438406
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of applied oral science : revista FOB 31:e20220447 PubMed37132700
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 15:141 PubMed36581994
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 20:520 PubMed36348351
2022
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 12:7476-7490 PubMed36438482
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:358 PubMed35436987
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com